Skip to main content
Clinical Trials/ACTRN12619000530123
ACTRN12619000530123
Completed
N/A

A prospective observational pilot study into the renal effects of using dexmedetomidine for sedation in intensive care

The Royal Melbourne Hospital IC0 sites12 target enrollmentApril 3, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sedation
Sponsor
The Royal Melbourne Hospital IC
Enrollment
12
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 3, 2019
End Date
January 1, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
The Royal Melbourne Hospital IC

Eligibility Criteria

Inclusion Criteria

  • Patients will be eligible for participation if their treating doctor was already intending to start them on this treatment (dexmedetomidine) for an existing clinical indication.

Exclusion Criteria

  • Patients will be excluded if aged less than 18 years, pregnant, or they have acute or chronic end stage kidney failure and are receiving renal replacement therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials